HC Wainwright & Co. Maintains Buy on Orchestra BioMed Hldgs, Raises Price Target to $12

Benzinga · 17h ago
HC Wainwright & Co. analyst Yi Chen maintains Orchestra BioMed Hldgs (NASDAQ:OBIO) with a Buy and raises the price target from $10 to $12.